CXCR4 and neoplasm: Only one patient (no. 4) showed higher tumor uptake compared with the other patients that indeed corresponded with locally moderate to strong CXCR4 tumor cell staining; unfortunately, due to a combination of factors there was not enough clinical support to proceed to therapy with [177Lu]Lu-Pentixather.